拉萨洛西德通过PI3K/AKT和JNK/P38 MAPK通路向下调节FOXM1来抑制黑色素瘤
Qiang Yuan1,2, Hangyu Jiang2,3, Maofei Zhu1,2
1Department of Pharmacy, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, Sichuan, China, 637003.
Journal of Cancer
|January 9, 2025
概括
拉萨洛西德是一种抗生素,通过抑制癌细胞生长和扩散,在治疗黑色素瘤方面表现有前途. 它通过通过特定的细胞通路调节FOXM1基因来起作用.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 黑色素瘤由于其侵袭性和有限的治疗选择而构成重大治疗挑战.
- 拉萨洛西德是一种离子体抗生素,已成为潜在的抗癌剂,但其在黑色素瘤中的机制在很大程度上仍未被阐明.
研究的目的:
- 研究拉萨洛西德作为黑色素瘤治疗剂的疗效.
- 阐明拉萨洛西德抗黑色素瘤作用背后的分子机制.
主要方法:
- 在体外测试以评估黑色素瘤细胞的增殖,迁移,入侵,细胞循环停止和细胞亡.
- 转录组测序和生物信息学分析以确定关键的调节基因.
- 在体外证实信号通路的参与 (PI3K/AKT,JNK/P38 MAPK).
- 在体内研究评估拉萨洛西德在抑制黑色素瘤生长中的有效性和安全性.
主要成果:
- 拉萨洛西德显著抑制了黑色素瘤细胞的增殖,迁移和入侵.
- 拉萨洛西德诱导黑色素瘤细胞的细胞周期停止和细胞亡.
- FOXM1被确定为拉萨洛西德抗黑色素瘤活性中的关键枢纽基因.
- 拉萨洛西德通过PI3K/AKT和JNK/P38 MAPK通路调节FOXM1的表达.
- 在体内研究表明有效抑制黑色素瘤生长,安全性良好.
结论:
- 拉萨洛西德作为黑色素瘤的治疗剂具有显著的潜力.
- 这项研究阐明了拉萨洛西德的作用机制,涉及通过PI3K/AKT和JNK/P38 MAPK通路调节FOXM1.
相关概念视频
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:07MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K